首页 | 本学科首页   官方微博 | 高级检索  
     

患者肿瘤组织来源的胶质母细胞瘤类器官的制备方法
引用本文:赖名耀,李少群,李新晨,邵媛,郁洁,李海南,李娟,胡清军,周江芬,艾茹玉,周兆明,林涛,金鑫,穆林森,欧阳辉,鲁明,范晓虎,蔡林波. 患者肿瘤组织来源的胶质母细胞瘤类器官的制备方法[J]. 中国肿瘤生物治疗杂志, 2022, 29(7): 659-664
作者姓名:赖名耀  李少群  李新晨  邵媛  郁洁  李海南  李娟  胡清军  周江芬  艾茹玉  周兆明  林涛  金鑫  穆林森  欧阳辉  鲁明  范晓虎  蔡林波
作者单位:1. 广东三九脑科医院 a. 肿瘤科; b. 病理科; c. 神经外 科,广东 广州 510510;2. 南京传奇生物科技有限公司,江苏 南京 211100
摘    要:目的:探讨胶质母细胞瘤(GBM)患者肿瘤组织来源的GBM类器官(GBO)模型的制备方法。方法:选取2021年广东三九脑科医院新诊断经病理确诊的8例GBM患者的新鲜肿瘤组织标本,将其剪成0.5~1 mm大小的组织碎片并用特制的培养基进行培养,待其成球且直径达到1 mm时剪小传代,同时选取培养2周以上的GBO进行石蜡包埋、切片,后进行H-E染色和免疫组化染色检测,并与亲本GBM组织进行组织学与细胞学的比较。结果:成功培养2例可传代冻存的GBO,并建立GBO生物库。H-E染色结果显示,GBO保留了与亲本GBM组织相似的组织结构和细胞形态;免疫组化实验结果显示,GBO与GBM组织中GFAP、OLIG2、Ki67和ATRX分子的表达情况一致。结论:将患者来源的GBM组织在体外剪小并用特制培养基培养,可构建与GBM患者肿瘤组织在组织和细胞层面一致的GBO。

关 键 词:胶质母细胞瘤  类器官  制备方法  组织鉴定
收稿时间:2022-03-24
修稿时间:2022-05-24

A preparation method for the organoid model of patient-derived glioblastoma
LAI Mingyao,LI Shaoqun,LI Xinchen,SHAO Yuan,YU Jie,LI Hainan,LI Juan,HU Qingjun,ZHOU Jiangfen,AI Ruyu,ZHOU Zhaoming,LIN Tao,JIN Xin,MU Linsen,OUYANG Hui,LU Ming,FAN Xiaohu,CAI Linbo. A preparation method for the organoid model of patient-derived glioblastoma[J]. Chinses Journal of Cancer Biotherapy, 2022, 29(7): 659-664
Authors:LAI Mingyao  LI Shaoqun  LI Xinchen  SHAO Yuan  YU Jie  LI Hainan  LI Juan  HU Qingjun  ZHOU Jiangfen  AI Ruyu  ZHOU Zhaoming  LIN Tao  JIN Xin  MU Linsen  OUYANG Hui  LU Ming  FAN Xiaohu  CAI Linbo
Affiliation:1. a. Department of Oncology; b. Department of Pathology; c. Department of Neurosurgery, Guangdong 999 Brain Hospital, Guangzhou 510510, Guangdong, China; 2. Nanjing Legend Biotech Co., Ltd, Nanjing 211100, Jiangsu, China
Abstract:Objective: To explore a preparation method for glioblastoma organoid (GBO) derived from patients with glioblastoma (GBM). Methods: The fresh tumor tissue samples of eight GBM patients newly diagnosed and pathologically confirmed in Guangdong 999 Brain Hospital in 2021 were selected, cut into tissue fragments of 0.5-1 mm in size and cultured in a special medium. When the tissue fragments grew into a spherical shape and the diameter reached 1 mm, they were cut into small pieces and passaged. GBOs cultured for more than 2 weeks were selected for paraffin-embedding, sectioned, and then stained with H-E and immunohistochemical staining. Histological and cytological comparisons were performed with parental GBM tissues. Results: Two cases of GBO that could be passaged and cryopreserved were successfully prepared and a GBO biobank was established. The results of H-E staining showed that GBOs retained tissue structure and cell morphology similar to those of the parental GBM tissues. The results of immunohistochemical analysis showed that the expressions of GFAP, OLIG2, Ki67 and ATRX in GBO and parental GBM tissues were basically consistent. Conclusion: GBO can be generated in vitro by trimming patient-derived GBM tissue and culturing it in a suitable medium. The GBO prepared by this method is consistent with the parental GBM tissue at the histological and cytological levels.
Keywords:glioblastoma (GBM)   organoids   preparation method   tissue identification
点击此处可从《中国肿瘤生物治疗杂志》浏览原始摘要信息
点击此处可从《中国肿瘤生物治疗杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号